Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (541-550 of 645) with videos related to

Pageof 65
Sort By:
Blood|January 21, 2014
Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohortsFrancesco Passamonti, Margherita Maffioli, Francisco Cervantes, et al.
Hematological Oncology|April 10, 2016
Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphomaManuel Gotti, Marta Nicola, Marco Lucioni, et al.
British Journal of Haematology|May 15, 2009
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromesAndrea Pellagatti, Teresa Marafioti, Jennifer C Paterson, et al.
Plos One|April 10, 2008
The role of the iron transporter ABCB7 in refractory anemia with ring sideroblastsJacqueline Boultwood, Andrea Pellagatti, Maryam Nikpour, et al.
Blood|January 29, 2013
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasmsMarzia Varettoni, Luca Arcaini, Silvia Zibellini, et al.
Blood|November 8, 2019
Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanningJessica L Bridgford, Su Min Lee, Christine M M Lee, et al.
Nature Communications|January 10, 2015
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromesMoritz Gerstung, Andrea Pellagatti, Luca Malcovati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromesAndrea Pellagatti, Axel Benner, Ken I Mills, et al.
American Journal of Hematology|November 23, 2013
Pregnancy complications predict thrombotic events in young women with essential thrombocythemiaMaria Luigia Randi, Irene Bertozzi, Elisa Rumi, et al.
Nature Communications|September 9, 2018
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasiaYusuke Shiozawa, Luca Malcovati, Anna Gallì, et al.
Pageof 65

Showing results (541-550 of 645) with videos related to

Sort By:
Pageof 65
Blood|January 21, 2014
Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohortsFrancesco Passamonti, Margherita Maffioli, Francisco Cervantes, et al.
Hematological Oncology|April 10, 2016
Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphomaManuel Gotti, Marta Nicola, Marco Lucioni, et al.
British Journal of Haematology|May 15, 2009
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromesAndrea Pellagatti, Teresa Marafioti, Jennifer C Paterson, et al.
Plos One|April 10, 2008
The role of the iron transporter ABCB7 in refractory anemia with ring sideroblastsJacqueline Boultwood, Andrea Pellagatti, Maryam Nikpour, et al.
Blood|January 29, 2013
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasmsMarzia Varettoni, Luca Arcaini, Silvia Zibellini, et al.
Blood|November 8, 2019
Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanningJessica L Bridgford, Su Min Lee, Christine M M Lee, et al.
Nature Communications|January 10, 2015
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromesMoritz Gerstung, Andrea Pellagatti, Luca Malcovati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromesAndrea Pellagatti, Axel Benner, Ken I Mills, et al.
American Journal of Hematology|November 23, 2013
Pregnancy complications predict thrombotic events in young women with essential thrombocythemiaMaria Luigia Randi, Irene Bertozzi, Elisa Rumi, et al.
Nature Communications|September 9, 2018
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasiaYusuke Shiozawa, Luca Malcovati, Anna Gallì, et al.
Pageof 65